Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
| Actual shortage: | 251 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CITALOPRAM | 40MG | TABLET | Resolved | 2021-07-15 | 2022-02-17 | 142622 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2021-07-15 | 2021-09-02 | 142619 |
| TEVA-BISOPROLOL | 5MG | TABLET | Resolved | 2021-07-15 | 2021-09-09 | 142616 |
| TEVA-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-07-15 | 2021-08-13 | 142613 |
| TEVA-AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-07-15 | 2021-09-09 | 142610 |
| TEVA-ONDANSETRON | 4MG | TABLET | Resolved | 2021-07-15 | 2023-04-28 | 142607 |
| TEVA-ONDANSETRON | 8MG | TABLET | Resolved | 2021-07-15 | 2023-04-28 | 142604 |
| TEVA-ROPINIROLE | 2MG | TABLET | Avoided shortage | 2021-07-15 | 2021-07-15 | 142581 |
| TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2021-07-15 | 2021-07-15 | 142578 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Avoided shortage | 2021-07-15 | 2021-07-15 | 142575 |
| TEVA-CAPTOPRIL | 50MG | TABLET | Resolved | 2021-07-08 | 2021-07-16 | 142210 |
| TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2021-07-08 | 2021-08-13 | 142207 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Resolved | 2021-07-08 | 2021-08-24 | 142204 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2021-07-08 | 2022-10-18 | 142201 |
| FENTORA | 200MCG | TABLET (EFFERVESCENT) | Resolved | 2021-07-08 | 2021-10-14 | 142198 |
| TEVA-CYCLOBENZAPRINE | 10MG | TABLET | Resolved | 2021-07-08 | 2021-12-08 | 142195 |
| TEVA-BROMAZEPAM | 3MG | TABLET | Resolved | 2021-07-08 | 2021-09-09 | 142192 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Resolved | 2021-07-08 | 2021-08-24 | 142189 |
| TEVA-TOPILENE | 0.05% | CREAM | Resolved | 2021-07-08 | 2021-09-02 | 142186 |
| TEVA-EMTEC-30 | 30MG 300MG | TABLET | Resolved | 2021-07-08 | 2021-09-02 | 142183 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |